6767.Two
6767.TWO operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
Business. 6767.TWO operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
6767.TWO operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
The company's capital structure is characterized by a low debt-to-equity ratio of 0.14, indicating a conservative leverage position. Its liquidity is strong, with a current ratio of 8.57, supported by cash and equivalents of TWD 91.8 million. The price-to-book ratio of 1.83 suggests the market values the company slightly above its book value, while the price-to-tangible-book ratio is identical, indicating no significant intangible assets.
Profitability metrics are negative, with a return on equity of -3.34% and a return on assets of -2.69%, reflecting a loss-making position. The company reported a net loss of TWD 19.1 million and an operating loss of TWD 28.4 million. These figures fall below the industry's median profitability metrics, which typically show positive returns for firms in the medical equipment and supplies sector.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of individual product lines or geographic regions.
The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent financial period. The operating cash flow is negative at TWD -4.7 million, and free cash flow is also negative at TWD -8.0 million. These figures suggest the company is not generating sufficient cash to fund operations or expansion, which could hinder future growth.
Risk factors include the company's negative net income and operating income, which could affect its ability to meet financial obligations. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the negative cash flows and operating losses may increase the likelihood of future dilution if the company needs to raise additional capital.
Recent events include the filing of the latest financial report, which disclosed the company's operating and net losses. No significant earnings call transcripts or other recent disclosures were available to provide further insight into the company's strategic direction or operational performance.
- The company has a strong liquidity position with a high current ratio and significant cash reserves.
- Profitability is negative, with both return on equity and return on assets below zero.
- The company's revenue is not diversified across segments or geographies, increasing exposure to regional risks.
- Growth is constrained by negative operating and free cash flows, which may limit the ability to fund expansion.
- The risk of dilution is currently low, but the company's financial performance could change this outlook.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- 6767.TWO Market data — financials · 2026-05-27